Clinical trials
Phase 1 Carcinoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Adaptimmune | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Blueprint Medicines Corporation | 1 |
| Cantargia AB | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Neovii Biotech | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 14 |
| Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasm Metastasis | 4 |
| Lung Neoplasms | 3 |
| Multiple Myeloma | 3 |
| Adenocarcinoma | 2 |
| Glioblastoma | 2 |
| Lymphoma | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.